R. Adams and K. Alitalo, Molecular regulation of angiogenesis and lymphangiogenesis, Nature Reviews Molecular Cell Biology, vol.17, issue.6, pp.464-478, 2007.
DOI : 10.1016/S0002-9440(10)63851-5

K. Marcelo, L. Goldie, and K. Hirschi, Regulation of Endothelial Cell Differentiation and Specification, Circulation Research, vol.112, issue.9, pp.1272-1287, 2013.
DOI : 10.1161/CIRCRESAHA.113.300506

Z. Cao, M. Bao, L. Miele, F. Sarkar, Z. Wang et al., Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis, European Journal of Cancer, vol.49, issue.18
DOI : 10.1016/j.ejca.2013.07.148

F. Pixley and E. Stanley, CSF-1 regulation of the wandering macrophage: complexity in action, Trends in Cell Biology, vol.14, issue.11, pp.628-638, 2004.
DOI : 10.1016/j.tcb.2004.09.016

V. Chitu and E. Stanley, Colony-stimulating factor-1 in immunity and inflammation, Current Opinion in Immunology, vol.18, issue.1, pp.39-48, 2006.
DOI : 10.1016/j.coi.2005.11.006

E. Lin and J. Pollard, Role of infiltrated leucocytes in tumour growth and spread, British Journal of Cancer, vol.296, issue.11, pp.2053-2058, 2004.
DOI : 10.1126/science.1068452

J. Curry, T. Eubank, R. Roberts, Y. Wang, N. Pore et al., M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In Vivo, PLoS ONE, vol.1452, issue.10, p.3405, 2008.
DOI : 10.1371/journal.pone.0003405.g007

L. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1091/mbc.9.4.875

R. Mcdermott, L. Deneux, V. Mosseri, J. Védrenne, K. Clough et al., Circulating macrophage colony stimulating factor as a marker of tumour progression, Eur Cytokine Netw, vol.13, pp.121-127, 2002.

P. Pouillart and F. Stanley, Circulating levels of the macrophage colony stimulating factor CSF-1

A. Sasaki, Y. Iwashita, K. Shibata, T. Matsumoto, M. Ohta et al., Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma, Surgery, vol.139, issue.6, pp.755-764, 2006.
DOI : 10.1016/j.surg.2005.10.009

R. Li, R. Marinelli, R. West, T. Nielsen, A. Beck et al., CSF1 Expression in Non gynecological leiomyosarcoma is associated with increased tumor angiogenesis, Am J Pathol, vol.179, pp.2100-2107, 2011.

M. Colonna, IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia, Nat Immunol, vol.13, pp.753-760, 2012.

D. Heymann, Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis, J Pathol, vol.221, pp.77-86, 2010.

H. Eda, J. Zhang, R. Keith, M. Michener, D. Beidler et al., Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood, Cytokine, vol.52, issue.3, pp.215-220, 2010.
DOI : 10.1016/j.cyto.2010.08.005

M. Chemel, L. Goff, B. Brion, R. Cozic, C. Berreur et al., Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients, Annals of the Rheumatic Diseases, vol.71, issue.1, pp.150-154, 2012.
DOI : 10.1136/annrheumdis-2011-200096
URL : https://hal.archives-ouvertes.fr/inserm-00667486

Y. Nakamichi, N. Udagawa, and N. Takahashi, IL-34 and CSF-1: similarities and differences, Journal of Bone and Mineral Metabolism, vol.21, issue.5, pp.486-495, 2013.
DOI : 10.1517/13543776.2011.545348

E. Buddingh, M. Kuijjer, R. Duim, H. Bürger, K. Agelopoulos et al., Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents, Clinical Cancer Research, vol.17, issue.8, pp.2110-2119, 2011.
DOI : 10.1158/1078-0432.CCR-10-2047

M. Maruszynski, S. Aukerman, and W. Wiktor-jedrzejczak, Impaired tumor growth in colonystimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma, Int J Cancer, vol.65, pp.112-119, 1998.